Top Ann Arbor, MI Biotech Companies (33)
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
The Life Sciences business of Truven Health Analytics (www.truvenhealth.com/life-sciences) is a trusted, full service market access, stakeholder management, and health economics and outcomes research (HEOR) consultancy serving the global pharmaceutical, medical device and biotech industry. With the 2014 acquisition of Heartbeat Experts (www.heartbeatexperts.com) into our Life Sciences business, we offer the leading KOL and market access stakeholder identification, profiling, mapping and engagement solutions. Truven Health Life Sciences enables our 150+ customers to effectively reach out to the right people with the right scientific evidence to demonstrate product value – anywhere in the world. (www.truvenhealth.com/life-science)
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).
Forever Labs banks your stem cells to help you live healthier, longer.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds
OncoFusion Therapeutics is engaged in the R&D of personalized therapeutics for patients with genetically defined cancers.
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD).
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP, P450, AChE and BChE Activity among others.
Accord Biomaterials, Inc. develops chemistries and coatings for medical device protection. It offers Nogen that are catalytic nitric oxide
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
MI Bioresearch is a contract research organization providing in vivo preclinical imaging services.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
Genetics Squared is a biotechnology company that develops solutions for personalized medicines.
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Called SoftVue™, and featuring proprietary TriAD™ (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast. This is something no other ultrasound system, currently available, can do. SoftVue has received 510(k) clearance from the U.S. Food and Drug Administration for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Formed in 2010 as a spin-out of Karmanos Cancer Institute in Detroit, MI, Delphinus is committed to creating improved imaging methods that assist medical professionals better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, and without concern of radiation or discomfort.
Work Your Passion. Live Your Purpose.
